Tenth week of pharmaceutical market: slowing growth in value and recovery in volume on 2022
In the week of March 6-12, the pharmacy market marks a setback that slows growth in value and recovery in volume over 2022, whose curves tend to become increasingly flat.
This is according to the report with which Iqvia updates to the first two and a half months figures and trend of the channel: in ten weeks, pharmacy totals a turnover of 5.16 billion euros, +2.3% in values over the same period in 2022, which is equivalent to almost 496 million packs, -3.3% in volumes.
THE PHARMACY MARKET AS OF THE 10TH WEEK OF 2023
Influencing the setback, in particular, is the slowdown in ethical drug, which in one week reduces value growth from 3.7 percent to 3.5 percent and volume growth from 2.1 percent to 1.8 percent over 2022.
ETHICAL DRUG, CONSUMPTION IN VALUES AND VOLUMES
COMMERCIAL AREA, THE TREND IN VALUE AND VOLUME
TRADE AREA, THE PERFORMANCE OF THE BASKETS
The free trade area, on the other hand, maintains the momentum even though the gain in value and volume is only a few tenths of a point.
Several slowdowns also among the commercial baskets, with only patient care growing by one point although the difference on 2022 remains sharply negative.
Growth in value and volume also markedly declined for personal care from 11.4 percent to 10.9 percent in sales and from 6.7 percent to 6.1 percent in packages sold.
The recovery of the vitamins and dietary supplements segment continues, declining, however, increases in value and volume for nutraceuticals.
BASKET OF PERSONAL CARE (PEC)
FOCUS PEC, DERMOCOSMETIC
FOCUS PEC, HAIR PRODUCTS
FOCUS OTC: VITAMINS AND SUPPLEMENTS
FOCUS OTC: FIBER-BASED LAXATIVES
FOCUS OTC: SYSTEMIC AND TOPICAL PRODUCTS FOR JOINTS
Quite a few braking among the commercial baskets as well, with only patient care growing by one point even though the difference on 2022 remains markedly negative.
PATIENT CARE BASKET (PAC)
NUTRITIONAL BASKETS, VALUES AND VOLUMES
NUTRITIONAL FOCUS, MEAL REPLACEMENT
Flying – as anticipated – are products related to seasonality, which benefit from the persistence of flu-like syndromes and cold ailments: flu and cold remedies grow in two months by 31% in value and 18.4% in volume over the same period in 2022. Nasal saline solutions score +65.3% and +59.7% respectively. Among seasonals, anti-flu and nasal saline solutions seem to have lost their momentum, immunostimulants hold.
SEASONALITY: ANTI-FLU AND ANTI-COLD
SEASONALITY: NASAL SALINE SOLUTIONS
Fonte: Marzo 2023, “Iqvia, nella decima settimana segnano il passo crescita a valori e recupero a volumi sul 2022”, pharmacy scanner.